REG - Primary Health Props - Dividend Declaration

Primary Health PropertiesAnnouncement

05/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230105:nRSE7235La&default-theme=true

RNS Number : 7235L  Primary Health Properties PLC  05 January 2023

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR
INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER
THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR
JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE
UNLAWFUL

 

Primary Health Properties PLC

("PHP" or the "Company")

 

Notice of Interim Dividend

and

Launch of Dividend Reinvestment Plan

 

The Company announces that the first quarterly interim dividend in 2023 of
1.675 pence per ordinary share of 12.5 pence each will be paid as to 1.34
pence by way of a Property Income Distribution ("PID") and the remainder as an
ordinary dividend on 23 February 2023 to shareholders on the register on 13
January 2023.

 

Certain qualifying shareholders may receive PIDs without deduction of
withholding tax and further details are available on the Company's
website www.phpgroup.co.uk (http://www.phpgroup.co.uk/) .

 

The Company also announces that it is inviting shareholders to participate in
a dividend reinvestment plan ("DRIP") in respect of the current interim
dividend and any future dividends.  The DRIP will be provided by Equiniti
Financial Services Limited ("Equiniti FS") and administered by PHP's
registrars, Equiniti Limited ("Equiniti"), and provides shareholders with the
opportunity to reinvest dividend payments to purchase additional ordinary
shares in PHP in the market.  A circular setting out full details of the DRIP
("Circular"), an application form to participate in the DRIP ("DRIP
Application Form") and the terms and conditions under which Equiniti FS will
be offering the DRIP will be posted to shareholders and published on PHP's
website later today.

 

Shareholders who hold their ordinary shares in certificated form and who wish
to participate in the DRIP will need to ensure that a completed DRIP
Application Form is received by Equiniti no later than 5:00pm on 3 February
2023 (the "Election Date").  Shareholders who hold their ordinary shares in
CREST and who wish to participate in the DRIP must do so by submitting an
election by CREST input message by the Election Date.

 

PHP is suspending the scrip dividend and will not be offering a scrip
alternative with this dividend.

 

The key dates for the dividend are detailed in the timetable below.

 

 Timetable
 Ex-dividend date                                                            12 January 2023
 Record Date                                                                 13 January 2023
 Latest date for receipt by Equiniti of DRIP Application Forms and input of  5:00pm on 3 February 2023
 CREST elections
 Dividend payment date/CREST credit date                                     23 February 2023
 Estimated DRIP purchase date                                                24 February 2023
 DRIP shares credited/certificates posted                                    1 March 2023

 

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

 

 

 

For further information:

 

Primary Health Properties PLC

Paul Wright, Company
Secretary
+44(0) 203 833 3344

Richard Howell, CFO
                                    +44(0)
203 833 3342

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVBIMRTMTJMBIJ